Polypharmacy among medicaid‐insured children with and without documented obesity

Objective Polypharmacy increases the risk of drug–drug interactions and adverse drug events. As obesity and rates of obesity‐associated comorbid chronic conditions continue to rise, an improved understanding of whether children with obesity experience higher risk of polypharmacy is needed. This stud...

Ausführliche Beschreibung